Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.2600 (6.22%) ($16.4100 - $17.3200) on Mon. Apr. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.91% (three month average) | RSI | 63 | Latest Price | $17.2600(6.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.1% a day on average for past five trading days. | Weekly Trend | HALO advances 4.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(52%) IWO(51%) IWM(47%) ARKG(45%) IWC(45%) | Factors Impacting HALO price | HALO will decline at least -1.955% in a week (0% probabilities). VIXM(-32%) VXX(-15%) UUP(-13%) TLT(-4%) USO(4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.955% (StdDev 3.91%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
5 Day Moving Average | $16.94(1.89%) | 10 Day Moving Average | $17.18(0.47%) | 20 Day Moving Average | $16.74(3.11%) | To recent high | -20.9% | To recent low | 24.2% | Market Cap | $2.359b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |